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Abstract 
The spectrum of agonist activity for three new 
homologs of histamine (cis- and trans-imidazolylallylamine 
and imidazolylpropargylamine) was evaluated in the isolated 
guinea pig ileum and right atrium. The homoiogs were about 
three log units less potent than histamine in stimulating 
contractions of the longitudinal muscles of the ileum, but they 
were histamine-like, pharmacologically, because they were 
sensitive to blockade by pyrilamine and resistant to blockade 
by atropine. In the right atrium, these weak agouists were 
partially sensitive to blockade by cimetidine. The agonist 
activity of the cis-isomer in particular was completely blocked 
by a combination of cimetidine and propranolol, but resistant 
to reserpine treatment (neuronal catecholamine depletion). 
Therefore, these homologs of histamine have the ability 
to stimulate H1- and Hz-histamine receptors and beta- 
adrenoreceptors in vitro. 
Introduction 
The structural and electronic properties of 
histamine which are required for activity at the 
Ha and H2 receptors have been the subject of 
extensive investigation over the years [1-9]. 
Methods employed have included cyclopropane- 
type rigid analogs [1], NMR studies [2,3], and 
molecular orbital calculations of the most stable 
conformations [3, 4, 6-9]. The most recent 
conclusions [8, 9], including a consideration of 
the selective H2-agonist dimaprit [10], were that 
the Ha-active conformation for histamine was 
likely to be a transoid cationic side chain with 
an uncharged imidazole able to rotate, and that 
the H2-active conformation of histamine was a 
cationic side chain of unspecified conformation 
attached to an uncharged imidazole that was 
capable of acting as a proton transfer agent 
through ring tautomerization. 
We have synthesized several unsaturated 
histamine homologs as potential inhibitors of 
diamine oxidase (DAO) [11, 12], and thought it 
would be of interest to measure histamine 
receptor activity for some of these homologs 
since such compounds have not previously been 
reported in the literature. In the work presented 
here we determined the extent of direct Ha- and 
Hz-histamine receptor interaction for three new 
unsaturated histamine homologs: cis and trans- 
imidazolylallylamine (cis- and trans-IAA, re- 
spectively) and imidazolylpropargylamine 
(IPPA) (Fig. 1). The major emphasis of our 
experiments was focused on the pharmaco- 
dynamics of cis-IAA because preliminary data 
[11] showed that the cis-isomer had a relatively 
l ow  Ki  (1.7 x 10-7 M) for inhibition of DAO 
[13]. For comparison, the activity of the 
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( IPA) ,  on  h i s t a m i n e  r e c e p t o r s  was  a lso  s tudied .  
I P A  h a d  b e e n  r e p o r t e d  as inac t ive  [14]. H o w e v e r ,  
we wi shed  to  test  the  h y p o t h e s i s  t ha t  s h o r t e n i n g  
the  p r o p y l  side c h a i n  l eng th  by  the  i n t r o d u c t i o n  
o f  u n s a t u r a t e d  ( d o u b l e  o r  t r iple)  b o n d s  b e t w e e n  
c a r b o n  a t o m s  a n d  the  c o n c o m i t a n t  i n t r o d u c t i o n  
o f  c o n f o r m a t i o n a l  r ig id i ty  in to  the  c h e m i c a l  
s t ruc tu res  m i g h t  i m p a r t  h i s t amine - l i ke  ac t iv i ty  
to one  o r  m o r e  Of these  c o m p o u n d s .  I n  the  s tudy  
o f  H1 r e c e p t o r  m e d i a t e d  ac t ions ,  we m e a s u r e d  
the  d o s e - r e l a t e d  inc rease  in the  i so ton i c  c o n t r a c -  
t ions  o f  l o n g i t u d i n a l  musc l e s  in the  i so l a t ed  
gu inea  p ig  i l eum.  F o r  Hz  r e c e p t o r  m e d i a t e d  
ac t ions  o f  these  agents ,  we s tud ied  the i r  ab i l i ty  
to inc rease  the  ra te  o f  s p o n t a n e o u s  c o n t r a c t i o n s  
in the  g u i n e a  p ig  r igh t  a t r i u m  in vitro. A 
p r e l i m i n a r y  r e p o r t  on  this  r e sea r ch  has  a p p e a r e d  
in F e d e r a t i o n  P r o c e e d i n g s  [15]. 
Material and Methods 
General Considerations. Isolated tissues from freshly 
killed animals were suspended in 10 ml jacketed tissue baths 
containing a physiological salt solution (PSS) maintained at 
36 C. The composition of the solution was (mM): NaC1, 
118; KC1, 4.7; MgCIz'6HzO, 0.54; CaC12.2H20, 2.5; 
NaHzPO4, 1.0; NaHCO3, 25 and glucose, 11. These 
chemicals were dissolved in double-distilled, demineralized 
water (DDDW). A mixture of oxygen (95%) and carbon 
dioxide (5%) was bubbled through the solution. 
lsolated guinea pig atria. Albino guinea pigs (Camm 
Research Institute, Inc.) weighing from 300 to 600 g were 
killed by a sharp blow to the head. The right atrium with 
the sinus node was removed from the animal and suspended 
in a 10 ml jacketed tissue bath. Spontaneous atrial contrac- 
tions were recorded via a Grass isometric force-displacement 
transducer (FT03C) connected to a Grass 4-channel 
polygraph (Model 79D). Simultaneously, a calibrated tacho- 
graph output (Model 7P4F) was used to convert the atrial 
rate into a linear recording. The resting atrial tension was 
0.5 g. The tissue was allowed at least 1 hr equilibration 
before a cumulative dose-response curve for an agonist was 
constructed. For those atria subjected to antagonists, the 
appropriate dose of the antagonist was added to the PSS 
1 hr before the initiation of the agonist dose-response curve. 
The chronotropic effect was recorded as the change in rate 
from the resting rate and expressed as a percentage of the 
maximal change in atrial rate (contractions/min) produced 
by histamine. 
Isolated guinea pig ileum. After the right atrium was 
removed from the animal, a 2 cm segment of the terminal 
portion of the ileum was removed and suspended in a 10 ml 
tissue bath. Contractions of the longitudinal ileal muscle 
were recorded via an E and M isotonic myograph transducer 
connected to a Narco 4-channel physiograph. The resting 
ileal muscle tension was 0.5 g. The tissue was allowed at 
least 1 hr equilibration in the tissue bath before a cumulative 
dose-response curve for an agonist was constructed. For the 
ileal preparations subjected to antagonists, the appropriate 
dose of the antagonist was added to the PSS 1 hr before the 
initiation of the agonist dose-response curve. Ileal contrac- 
tions were expressed as a percentage of the maximal contrac- 
tile response to histamine. 
Drugs. All drug solutions were freshly prepared with 
DDDW. Serial dilutions of the solutions were made with 
DDDW. The following substances were used: histamine 
2HC1 and tyramine HC1 (Regis Chemical Co.), pyrilamine 
maleate, cimetidine and dl-propranolol (Sigma Chemical 
Co.); atropine sulfate monohydrate, (Aldrich Chemical Co.); 
reserpine (Ciba Pharmaceutical Co.). The histamine 
homologs cis- and trans-IAA, IPPA (unsaturated homologs) 
and IPA (saturated homolog) were synthesized in the 
medicinal chemistry laboratories of the University of 
Michigan College of Pharmacy. 
Statistical Evaluation. The log dose-response relation- 
ships were expressed in tabular or graphical form as the 
mean + S.E.M. Where appropriate, a statistically significant 
difference between groups of data was established with the 
aid of Student's t-test, and p < 0.05 (two-tailed test) was 
accepted as statistically significant. 
For those atria or ilea exposed to antagonists, the 
dissociation constant (KB) of the receptor-antagonist 
complex was calculated by the method described by 
Furchgott [16]: 
KB = [Antagonist]/Dose-ratio - 1. 
Dose-ratio is defined as the ratio of ECs0 concentrations of 
the agonist in the presence and absence of the antagonist. 
The concentration of antagonist is expressed in moles/liter. 
The slopes of the log dose-response relationships for an 
agonist in the absence or presence of an antagonist were 
subjected to least squares linear regression analysis within 
the EC2o to ECso dose range. The nul hypothesis that the 
linear regression lines were parallel (no statistically signifi- 
cant difference in slopes) was accepted or rejected with the 
aid of the Pharmacological Calculation System (Pharm/ 
PCS Version 3.0, 1984) obtained from MicroComputer 
Specialists (Elkins Park, PA). The computations were 
performed on an International Business Machines Personal 
Computer. 
Results and Discussion 
Comparison of effects of histamine and 
histamine homologs on isolated ilea and atria. 
All  o f  the  h o m o l o g s  e x h i b i t e d  a g o n i s t  ac t iv i ty  
in the  g u i n e a  p ig  i l e u m  o r  a t r i u m ,  b u t  t hey  were  
m u c h  w e a k e r  agon i s t s  t h a n  h i s t a m i n e  (Fig .  2). 
I P A  a n d  c i s - I A A  h a d  a re la t ive ly  g r ea t e r  af f in i ty  
fo r  i leal  o r  a t r i a l  r e c e p t o r s  t h a n  d id  I P P A  ( T a b l e  
1). T h e  cis- a n d  t r a n s - i s o m e r s  o f  I A A  w e r e  n o t  
s t e reose lec t ive  fo r  r e c e p t o r s  in e i the r  t issue.  
P r e t r e a t m e n t  o f  a t r i a l  o r  i leal  t i ssue p r e p a r a t i o n s  
fo r  1 h r  w i t h  a s u p r a m a x i m a l  d o s e  o f  a m i n o -  
g u a n i d i n e  (0.1 r aM) ,  a n o n c o m p e t i t i v e  D A O  
i n h i b i t o r  [17], d id  n o t  p o t e n t i a t e  (i.e. d id  n o t  
p r o d u c e  a l e f t w a r d  shi f t  o f )  t he  d o s e - r e s p o n s e  
r e l a t i o n s h i p  fo r  c i s - I A A  o n  e i the r  i leal  o r  a t r i a l  
t issues (da ta  n o t  shown) .  Identification of 
receptors mediating homolog activity by block- 
ade with selective receptor antagonists. 
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Figure 2 
Cumulative dose-response relationships of histamine ((3) 
and the histamine homologs: IPA (O); CIS-IAA (V), trans- 
IAA ( 9  and IPPA ((3). Cumulative responses to histamine 
were obtained after complete washout of a particular 
homolog which was assumed to coincide with the return to 
pre-homolog baseline conditions. A. Isotonic contraction 
induced in longitudinal smooth muscles of the isolated 
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terminal portion of guinea pig ileum (n=4-10). B. 
Stimulatory effects on atrial contraction rate (ACR) of the 
isolated guinea pig right atrium (n = 4-7). Mean baseline 
ACR prior to homolog dose-response curves in these 
experiments has 179 4- 4 contractions/min. Symbols with 
attached vertical bars in this figure (and all subsequently 
appearing figures) represent the mean (4- SEM) response. 
Table 1 
Comparison of-log ECso values for histamine and histamine 
homologs a on isolated ilea and right atria from guinea pigs 
- log  ECso  [M] 
I L E A  R.  A T R I A  
H i s t a m i n e  7.33 4- 0.01 b 6.01 4- 0 .06 
(6) (6) 
IPA 4.08 4- 0.12 3.94 4- 0,12 
(7) (8) 
cis-IAA 3.98 4- 0.07 3.86 4- 0.12 
(10) (4) 
trans-IAA 3.60 4- 0.11 3.61 4- 0.05 
(4) (4) 
I P P A  3.35 4- 0 .12 ~ 3.36 4- 0 .12 c 
(7) (8) 
"-Log ECs0 values for homologs calculated at the level of 
a one-half maximal response to histamine. 
bValues represent the mean 4- S.E.M. Numbers in paren- 
theses are number of animals used. 
CThe affinity (-logECso) of IPPA for ileal or atrial receptors 
was significantly less than that for IPA or cis-IAA (p < 0.05, 
t-test). 
Ha h&tamine receptor blockade 
Pyrilamine maleate (PAM), a selective H 1 
histamine receptor blocker, was used to deter- 
mine if the stimulation of  ileal contraction by 
the homologs was mediated by H1 receptors. In 
preliminary experiments, PAM (5 nM) treatment 
for 1 hr produced an 11.5-fold parallel shift to 
the right in the dose-response relationship for 
histamine. The -log KB (9.32, Table 2) calculated 
from this shift was in good agreement with 
published values of about  9.3 [18]. Therefore, 
PAM produced classical competitive antagon- 
ism of the response to histamine in the guinea 
pig ileum. 
PAM produced dose-dependent decreases 
in apparent  potency ofcis- and trans-IAA, IPPA 
and IPA on ileal muscles (Fig. 3 and Table 2). 
Complete dose-response curves for the un- 
saturated homologs in the presence of  PAM 
could not be produced in all experiments because 
of  the relatively low affinity of  the ileal receptors 
for these homologs. In spite of  that limitation, 
the rightward shift (dose-ratio) in the dose- 
response relationships of  cis- or t rans-IAA and 
IPPA in the presence of  PAM (1 or 5 nM) could 
be interpreted as classical competitive antagon- 
ism (Table 2 and Figs 3A, B, C). At  higher 
concentrations PAM (10 or 100 nM) completely 
blocked the ileal responses to these homologs. 
The decrease in maximal effect which was quite 
apparent  with PAM (5 nM) blockade of  the 
cis-IAA response may be related to the fact that 
cis-IAA was a weak agonist in comparison to 
histamine (Fig. 2). Blockade of  the response to 
a weak agonist by a strong antagonist is known 
to produce a decrease in the maximal effect in 
addition to the expected shift in the apparent  
potency of  the weak agonist [19]. 
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Table 2 
Evidence for H~-histamine receptor activation by unsatura ted histamine homologs 
-LOG EC" [M] 
% 
D R U G  n b EFFECT C O N T R O L  P Y R I L A M I N E  LOG(DR~-I)  -LOG KB d 
Histamine 6 50 7.33 + 0.01 6.27 4- 0.04 1.02 9.32 
[51 ~ 
cis-IAA 4 50 4.04 + 0.07 3.45 4- 0.05 0.46 r 9.45 
[ll 
t rans- IAA 4 30 4.22 4- 0.11 3.30 4- 0.22 0.86 9.15 
[51 
IPA 4 40 3.69 4- 0.12 2.52 4- 0.15 1.14 9.45 
[51 
" E C =  Effective Concentration: concentration that  produced the response (700 of 
histamine maximum) used to calculate the dose ratio (DR) for each agonist. 
bn = number  of experiments. 
CDR (Dose Ratio): the effective concentration (EC) at which a particular response 
occurred in the presence of  an antagonist  divided by the EC at which the response 
occurred in the absence of the antagonist.  
aKB is the dissociation constant  of  the antagonist-receptor complex which is defined as 
the concentration of  antagonist  that causes a 2-fold shift to the right in the dose-response 
curve for an antagonist.  
r  of  pyrilamine used to obtain the Dose-Ratio (DR). 
rCalculated with pyrilamine (1 nM); at 5 nM the dose-response curve for cis-lAA was 
depressed by pyrilamine (see fig. 3). 
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Figure 3 
Inhibition ofhomolog- induced ileal contractions by pyrilamine maleate (PAM). 3A, B and C: PA M (1 or 5 nM,  i hr) produced 
a shift to the right in the cumulative dose-response relationship for cis- and trans-IAA and IPPA. The slopes o f  the curves 
in the absence or presence of  P A M  were not  significantly different when compared by least squares regression analysis. 3D. 
IPA-induced ideal contractions were comparatively more resistant to blockade by PAM (n = 4-7 for all curves). 
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The ileal response to IPA was considerably 
more resistant to blockade by PAM (Fig. 3D). 
Pam (5-500 nM) suppressed in a dose-related 
manner but did not completely block the ileal 
contractions to IPA. The -log KB for PAM 
calculated from the dose-ratio shift (4.28) with 
IPA in the absence or presence of PAM (5 nM) 
was 8.81. This was about 0.5 log unit less than 
the expected value of 9.3. This fact together with 
the above-mentioned resistance to PAM block- 
ade may indicate that IPA was sensitive to both 
competitive and noncompetitive inhibition by 
PAM. The lower -log KB value for PAM 
indicates that the affinity of PAM for this site of 
blockade was lower than for the competitive site 
(Hi-receptor). 
Muscarinic cholinergic receptor blockade. 
Homolog-induced contractions of longitudinal 
ileal muscle were completely resistant to block- 
ade by atropine sulfate (1 pM), a selective 
blocker of muscarinic cholinergic receptors (data 
not shown). Thus, no muscarinic cholinergic 
agonist activity was present in these histamine 
homologs. 
Ha-histamine receptor blockade 
Cimetidine (CD), a selective H2-receptor 
blocker was used to determine if the homolog- 
induced stimulation of the atrial contraction rate 
(ACR) was mediated by histamine receptors. CD 
treatment did not affect the baseline ACR which 
was 175 (4-6.4) contractions/min prior to CD 
and 182.5 (•  9.4) for the same atria treated with 
CD (100/~M, 1 hr). In preliminary experiments, 
CD (10 #M) produced a 12.6-fold rightward 
shift in the dose-response curve for histamine 
(data not shown). The -log KB calculated for 
CD was 6.1, which was in good agreement with 
previously published results [20]. 
The cis-IAA-induced increases in ACR were 
resistant to blockade by CD (10 #M) (Fig. 4). 
None of the homologs were blocked entirely by 
CD. IPA was the most sensitive of the four 
homologs to CD. However, a 10-fold increase 
in the concentration of CD (100 #M) produced 
no further decrease in the response to IPA. CD 
concentrations in excess of 100 /~M were not 
used in these experiments because (i) in general, 
the use of an antagonist at a concentration 
greater than 100 times the KB is almost certain 
to block receptors other than the specific 
receptor [20], and (ii) at high concentrations 
cimetidine noncompetitively blocks beta- 
adrenoceptors [21]. Since the homologs were 
partially sensitive to antagonism by CD, the 
mechanism of action for these agonists may be 
related to more than one receptor system. 
Blockade of H2-receptors and beta-receptors 
Atria were treated with CD (100 #M) and 
propranolol (PRO), a beta-adrenoceptor blocker 
(1 #M, 1 hr) and then dose-response curves for 
the homologs were performed. The combined 
antagonism produced by CD and PRO com- 
pletely blocked the increases in ACR produced 
by cis-IAA or IPA (Fig. 4A and B). Therefore, 
adrenoceptors and histamine receptors both 
mediate the increase in ACR produced by these 
homologs in the isolated guinea pig right atrium. 
Blockade of  adrenergic neurons 
The following experiment was performed to 
determine whether cis-IAA was acting directly 
on the beta-adrenoceptors in the sinus node or 
as an indirect agonist by the release of catecho- 
lamine stores in adrenergic neurons that inner- 
vate the nodal tissue. One animal was treated 
with reserpine (3 mg/kg, ip); the other (control) 
received a saline injection (1 ml, ip). The right 
atria were removed from both animals 16 hr 
later and were placed in the same tissue bath 
(i.e., 'paired'). Cis-IAA produced quantitatively 
similar (-log ECs0 = 3.85 and 3.55) dose-related 
increases in ACR in both control and reserpine 
treated atria (Fig. 5) that were comparable to 
the mean control value for the cis-isomer in atria 
(Table 1). After washout of the effect of the 
cis-isomer, both atria received tyramine HC1 
(10-300 pM), an indirect (catecholamine releas- 
ing) adrenergic agonist. The reserpine-treated 
atrium was unresponsive to tyramine (Fig. 5B). 
Reserpine had depleted the readily releasable 
catecholamine stores in the adrenergic nerve 
terminals but did not affect the atrial response 
to cis-IAA. Therefore, cis-IAA was a direct 
acting agonist on beta-adrenoceptors in the atrial 
sinus node tissue. 
Conclusions 
On the basis of the apparent affinities of 
the homologs for receptors in the ileum, it would 
be likely to assume that no selectivity for Ha or 
H 2 receptors existed in these compounds. How- 
ever, a comparison of sensitivity of these agonists 
to selective Ha and H2 blockers revealed some 
important differences in their mechanisms of 
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Figure 5 
Evidence that rate-increasing effect of  cis-IAA was not 
mediated by catecholamine release. Atrial responses to 
tyramine-induced release of  neuro-transmitter were recorded 
after washout of  cis-IAA. A. Control guinea pig received a 
I ml injection of  saline (ip) 16 hrs prior to sacrifice. B. 
Reserpine treated guinea pig. Depletion oftyramine sensitive 
neuro-transmitter stores was indicated by lack of  response 
to tyramine. Both atria were mounted in the same tissue 
bath in this experiment and, therefore, received identical 
exposure to these agonists. 
action (Figs 3 and 4). For example, cis-IAA was 
relatively sensitive to H1 receptor blockade but 
resistant to H2 blockade. Thus, cis-IAA is 
structurally more compatible with H1 receptors. 
In the atrium, the major receptor system con- 
tributing to the apparent affinity of cis-IAA for 
atrial chronotropic sites were the beta-adreno- 
ceptors. In contrast, IPA, the saturated propyl 
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homolog, was the least sensitive to H 1 receptor 
blockade but the most sensitive to Hz blockade. 
This structure-activity observation for IPA 
seems to correlate with the activity of  the 
selective H2 agonist dimaprit in which a fully 
saturated thio-propyl side chain separates the 
amino group from the tautomeric group. 
If  any advantage was to be gained by 
shortening the distance between the tautomeric 
imidazole group and the amino group in the side 
chain of  the IPPA homolog, the advantage was 
readily offset by the rigid, linear nature to the 
side chain imparted by the introduction of the 
triple bond between the beta and gamma carbon 
atoms. This structural rigidity of IPPA may have 
accounted for its low ranking in terms of  
apparent affinity for receptors in either the ileum 
or atrium. 
The average difference in apparent affinity 
of cis-IAA for receptors in the atrium or ileum 
(about 1.2 x 10 -4 M) and the binding sites in 
the enzyme DAO (1.7 x 10 -7 M) [11] is slightly 
over 700-fold. Cis-IAA can therefore be properly 
classified as a selective inhibitor of diamine 
oxidase. The apparent affinity of  cis-IAA for 
DAO compares favorably with other inhibitors 
of this enzyme such as aminoguanidine which 
has an apparent affinity of 1.07 x 10-8 M [13]. 
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